Hint mode is switched on Switch off
For swift navigation between sections

Caris Life Sciences
LEI 549300LX5LO78M5VPY43

PDF download

Choose all Reset all
Download Cancel
Organization name
Caris Life Sciences Inc
Country name
USA
Country of registration
USA
Industry
Medical Services
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Caris Life Sciences, Inc. operates as an artificial intelligence techbio and precision medicine company. The Company commercializes and develops solutions to transform healthcare through the use of comprehensive molecular information and machine learning algorithms. Caris Life Sciences serves patients worldwide.

Awards

News

04/06/2026 Caris Life Sciences: Submission Of Matters To A Vote Of Security Holders
29/05/2026 Caris Life Sciences (NASDAQ:CAI): AI-Driven Healthcare and Capital Efficiency Analysis
09/05/2026 Caris Life Sciences (NASDAQ:CAI) Faces Market Pressure Amid Strong Revenue Growth
08/05/2026 Caris Life Sciences (NASDAQ:CAI) Reports Strong Q1 Earnings and Robust Financial Health
12/01/2026 Caris Life Sciences: Results Of Operations And Financial Condition, Regulation Fd Disclosure, Financial Statements And Exhibits
All organization news

Documentation

IFRS/US GAAP reports

2025
III q eng
IV q eng
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    549300LX5LO78M5VPY43
  • SIC
    8071 SERVICES-MEDICAL LABORATORIES
  • CIK
    0002019410
  • EIN
    85-2077369
Registration is required to get access.